Feasibility of Telemedicine Medical Abortion

NCT ID: NCT04599725

Last Updated: 2022-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

413 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-01

Study Completion Date

2021-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant people

medical abortion

Intervention Type DRUG

medical abortion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

medical abortion

medical abortion

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* desires abortion

Exclusion Criteria

* medically ineligible for procedure
Minimum Eligible Age

10 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gynuity Health Projects

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elizabeth Raymond, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Gynuity Health Projects

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Planned Parenthood of the Rocky Mountains

Denver, Colorado, United States

Site Status

Carafem

Washington D.C., District of Columbia, United States

Site Status

Carafem

Atlanta, Georgia, United States

Site Status

The University of Hawaii Women's Options Centers

Honolulu, Hawaii, United States

Site Status

Carafem

Skokie, Illinois, United States

Site Status

Emma Goldman Clinic

Iowa City, Iowa, United States

Site Status

Maine Family Planning

Augusta, Maine, United States

Site Status

Carafem

Chevy Chase, Maryland, United States

Site Status

Maine Family Planning

Boston, Massachusetts, United States

Site Status

Planned Parenthood Minnesota, North Dakota, South Dakota

Saint Paul, Minnesota, United States

Site Status

Planned Parenthood of Montana

Billings, Montana, United States

Site Status

Planned Parenthood of the Rocky Mountains

Albuquerque, New Mexico, United States

Site Status

Maine Family Planning

New York, New York, United States

Site Status

Planned Parenthood Columbia Willamette

Portland, Oregon, United States

Site Status

Planned Parenthood Columbia Willamette

Vancouver, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1049

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mail Order Mifepristone Study
NCT03913104 COMPLETED PHASE4